Cochrane Database of Systematic Reviews 2004
DOI: 10.1002/14651858.cd000019.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2004
2004
2013
2013

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(9 citation statements)
references
References 32 publications
0
9
0
Order By: Relevance
“…Following advice of the obstetric consultants, two indicators were removed: the proportion of women with singleton pregnancies at risk of preterm delivery to be treated with a combination of corticosteroids with thyrotropin-releasing hormone [33], and the proportion of breech deliveries carried out by caesarean section [32]. The main reasons for excluding these indicators were: the first is an intervention no longer used in clinical practice, and the existing evidence on the second is controversial in nature.…”
Section: Resultsmentioning
confidence: 99%
“…Following advice of the obstetric consultants, two indicators were removed: the proportion of women with singleton pregnancies at risk of preterm delivery to be treated with a combination of corticosteroids with thyrotropin-releasing hormone [33], and the proportion of breech deliveries carried out by caesarean section [32]. The main reasons for excluding these indicators were: the first is an intervention no longer used in clinical practice, and the existing evidence on the second is controversial in nature.…”
Section: Resultsmentioning
confidence: 99%
“…Side effects are more likely to occur in women receiving TRH. In the infants, prenatal TRH increases 16% the risk of needing ventilation, 48% having a low Apgar score at five minutes, and, for the two trials providing data, was associated with poorer outcomes at childhood follow-up (22).…”
Section: Thyrotropin-releasing Hormonementioning
confidence: 95%
“…Prenatal thyrotropin-releasing hormone (TRH), in addition to corticosteroids, given to women at risk of very PTB, does not improve infant outcomes and can cause maternal side effects (22). Overall, prenatal TRH, in addition to corticosteroids, does not reduce the risk of neonatal respiratory disease or chronic oxygen dependence, and does not improve any of the fetal, neonatal, or childhood outcomes.…”
Section: Thyrotropin-releasing Hormonementioning
confidence: 99%
“…For example, preclinical research studies suggested that antenatal thyrotrophin-releasing hormone might act synergistically with corticosteroids to reduce the risk of respiratory distress syndrome in preterm infants. Despite the biological plausibility of this treatment, plus evidence of effect in animal models and encouraging findings from some trials, the Cochrane systematic review did not show any improvement in important outcomes but did find evidence of important adverse effects for mothers and infants 13. The potential for bias in the review was further reduced because the reviewers identified and included data previously reported in abstract form only and analysed data using “intention-to treat” principles.…”
Section: How Have Cochrane Reviews Influenced Practice?mentioning
confidence: 99%